China's agriculture ministry approved the doxycycline hydrochloride tablets and classical swine fever virus vaccine produced by Zhejiang Hisun Pharmaceutical (SHA:600267) subsidiary Zhejiang Hisun Animal Health Products.
The antibiotic is indicated for infections caused by gram-positive and gram-negative bacteria, as well as mycoplasma, according to a Wednesday filing with the Shanghai bourse.
Hisun's classical swine fever virus E2 protein recombinant baculovirus helps prevent the disease with an immunity period of six months.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments